Josh Gottheimer
Josh Gottheimer (D-NJ) bought $1K-$15K of $GILD (Gilead Sciences, Inc. - Common Stock) on Jan 27, 2026, part of 6 transactions in this filing (2 buys, 4 sells).
HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Companies in this filing · 6
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Suspicious Timing Detected
5 flagsJosh Gottheimer sold $1,001 - $15,000 in $UBER on 2026-01-30 — 34 days before S4010, 'A bill to clarify the classification of service provider payees as employees or independent contractors in Federal law,' was introduced. This bill could increase operational costs for gig economy companies.
Josh Gottheimer bought $1,001 - $15,000 in $ICE on 2026-01-26 — 37 days before HR7127, the 'Restoring the Secondary Trading Market Act,' was introduced. This bill aims to increase liquidity and trading volume in the off-exchange secondary debt market.
Josh Gottheimer bought $1,001 - $15,000 in $ICE on 2026-01-26 — 52 days before HR8007, the 'SILVER Act,' was introduced. This bill mandates geographical diversification for precious metals depositories, which could increase competition.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $GILD | Gilead Sciences, Inc. - Common Stock | $1K-$15K | $140.97 | $130.63 | -7.3% | Jan 27, 2026 |
| BUY | $ICE | Intercontinental Exchange Inc. Common Stock | $1K-$15K | $175.10 | $152.87 | -12.7% | Jan 26, 2026 |
| PARTIAL SELL | $NSRGY | NESTLE S.A S/ADR | $1K-$15K | $92.49 | $99.64 | +7.7% | Jan 26, 2026 |
| SELL | $SNDR | Schneider National, Inc. Common Stock | $1K-$15K | $29.92 | $32.81 | +9.6% | Jan 26, 2026 |
| SELL | $NOW | ServiceNow, Inc. Common Stock | $1K-$15K | $117.01 | $100.44 | -14.2% | Jan 30, 2026 |
| PARTIAL SELL | $UBER | Uber Technologies, Inc. Common Stock | $1K-$15K | $80.05 | $73.80 | -7.8% | Jan 30, 2026 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
GAP Supply Act
The GAP Supply Act (HR7528) is an early-stage procedural bill with no funding authorization. It extends a regulatory timeline for compounding facilities during drug shortages but has near-zero near-term market impact. Current real market data shows $VTRS at $15.04 within its 52-week range of $8.19–$16.47, with a +11.32% 30-day gain reflecting broader market trends, not this bill.
Small Business Relief Act
HR4130, the Small Business Relief Act, amends SEC registration thresholds to exclude qualified institutional buyers and institutional accredited investors from the shareholder count. This reduces the likelihood and urgency for private companies to go public, directly weighing on future listing revenue for exchange operators. The bill is actively progressing through the House with committee approval and a Union Calendar placement, but remains in early legislative stages.
Modern Worker Security Act
HR1320 (Modern Worker Security Act) moved to the Union Calendar on 2026-02-20 after clearing committee 19-16. The bill removes the federal legal risk that offering portable benefits to independent contractors triggers employee reclassification. This is directly bullish for $UBER ($74.47), $LYFT ($14.34), $DASH ($169.33), and $ABNB ($140.28) — all of which face tens of billions in potential liability if forced to reclassify workers. The bill preserves their independent contractor business models while unilaterally removing the legal barrier to offering benefits as a competitive tool.
Break Up Big Medicine Act
The Break Up Big Medicine Act (S.3822) targets the vertical integration of healthcare giants by prohibiting common ownership of PBMs, insurers, and drug wholesalers. In early committee stage with bipartisan sponsorship, the bill poses a structural risk to UnitedHealth Group's business model while potentially easing pricing pressure on pharmaceutical manufacturers like Pfizer.
Restoring the Secondary Trading Market Act
HR7127 removes state-level blue-sky regulatory burdens on off-exchange secondary debt trading. The bill is on the House Union Calendar with committee approval, signaling active legislative momentum. $ICE and $CME are structurally positioned to benefit from reduced compliance costs and expanded trading volumes on their electronic fixed-income platforms.
To require the Secretary of State, in consultation with the Secretary of Health and Human Services and other relevant departments and agencies, as appropriate, to formulate a strategy for the Federal Government to secure support from foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, and for other purposes.
The SUPER BUGS Act (HR7879) is a procedural bill with zero funding, no procurement mechanism, and no regulatory impact. It requires the State Department to develop a strategy for international pandemic product collaboration. Market impact is negligible — recent price moves in $PFE (-1.41% 7d), $MRNA (-7.27% 7d), $JNJ (+1.01% 7d), and $GILD (+0.18% 7d) reflect broader sector trends, not this legislation.
Fair Markets and Sports Integrity Act
HR7477 is an early-stage bill that would ban commodity exchanges from listing sports-event or casino-game contracts. It has zero near-term financial impact on any company because no such products currently exist or generate revenue at CME or ICE. For sportsbook operators DraftKings and PENN Entertainment, the bill removes a speculative competitive threat from regulated derivatives markets.
HILTON Act
The HILTON Act (HR7551) is an early-stage bill referred to committee that would ban federal agencies from contracting with companies that discriminate against federal law enforcement officers. It authorizes zero funding and has a long legislative path ahead. Market impact is negligible — federal contract revenue is a low-single-digit percentage for all affected tickers. Recent price moves in $CAR (-59% 7-day), $HLT (-3.44%), $MAR (-1.45%), and $IHG (-1.1%) are driven by company-specific fundamentals, not this bill.
A bill to clarify the classification of service provider payees as employees or independent contractors in Federal law.
S.4010 is an early-stage Senate bill that would reclassify independent contractors as employees under federal law. Despite minimal legislative momentum, the policy threat is real, and gig economy stocks — $UBER, $LYFT, $DASH, and $UPWK — have already priced in some risk, with $UPWK hitting near its 52-week low of $10.18 on April 30, 2026.
Small Business Investor Capital Access Act
S.3880 is a procedural bill that modestly raises the private fund adviser registration threshold from $150M to $175M AUM. It has no authorized funding, no tax changes, and no sector-level revenue impact. The bill remains in committee with only one cosponsor and low legislative odds in the 119th Congress. For large publicly traded asset managers like Blackstone ($BX) and KKR ($KKR), which operate far above the threshold, this bill is procedurally irrelevant.
Other Filings by Josh Gottheimer
Free — no credit card
Get the next Gottheimer trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.